• Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Twitter Social Icon

© 2019 eSense-Lab Limited (ASX:ESE) Ltd.

ASX CODE: ESE

Leadership

Itzik Mizrahi

 CEO
Itzik joined eSense - Lab in March 2020 and serves as the CEO of the company. Itzik brings vast experience in commercial, medical and clinical management roles in global Pharmaceutical companies. Over more than the past decade he was Country Manager (Israel) at Actelion Pharmaceuticals, leading commercial activity, overseeing clinical trials, medical and regulatory processes. This included, for several years, regional operations management for Israel, Greece and Turkey. Under his leadership, Actelion Israel repeatedly overshot benchmark sales predictions and company goals. Following Actelion’s merger into JNJ, Itzik remained in position for 2 years, to ensure seamless organizational post-merger integration. Prior to this, Itzik was Medical Affairs Manager at MSD Israel, and before that, he served as Head of Clinical Operations at Pfizer Israel. All these positions involved operational and regulatory communications across global/multinational entities

Moshe Hukaylo

CFO

Moshe, CPA, MBA, joined eSense – Lab in March 2020, Moshe has vast CFO experience in public and private companies. Moshe served as CFO of Pfizer Israel and prior to that in Merck-Serono Israel and In InterPharm. Moshe has extensive experience in financial management, business strategy, process improvement and supply chain. Accompanies fast-growing companies from early stage through the regulated arena of public companies."

Eyal Kalo
CTO

Eyal Kalo earned his Ph.D from the Weizmann Institute of Science following an extensive research around mutant p53 protein and its contribution to cancer initiation and progression.
Eyal completed his studies at 2010 and joined the biotechnology industry where he gained expertise in the development of cell based and cell free assays for drug discovery, diagnostic and skin care applications. In parallel, Eyal acquired an extensive knowledge and experience in project management. He was responsible for driving the development of various projects from concept to launch in the field of Pharmaceutical, Medical devices, Nutraceutical and Cosmetics.  .

 

Maya Sapir-Mir

Head of the Bio-Botanic Unit

Maya Sapir-Mir is a domain expert in plant genetics and metabolic engineering. She has extensive experience in plant genetics, molecular biology, protein biochemistry, and cell biology. Dr.Sapir-Mir earned an M.Sc. in genetics and breeding at the Faculty of Agriculture, Food and Environmental Quality Sciences and a Ph.D. in plant sciences, both from the Hebrew University of Jerusalem. Furthermore, she has conducted extensive research as part of her post-doctorate work on the agricultural research organization (ARO).